ExpreS2ion Biotech Holding AB (publ)
STO: EXPRS2.ST0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Stockholm Stock Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Bent U. Frandsen
- Employees
- 20
- Headquarters
- Horsholm, Denmark
- IPO year
- 2016
- Market cap
- SEK 5.3M
- Website
- https://www.expres2ionbio.com
Loading EXPRS2…
Loading profile data…Frequently asked questions about EXPRS2
What does ExpreS2ion Biotech Holding AB (publ) (EXPRS2.ST) do?
ExpreS2ion Biotech Holding AB (publ), through its subsidiary, ExpreS2 ion Biotechnologies ApS, develops and produces complex proteins for vaccines and diagnostics in Denmark. The company develops capsid virus-like particle COVID-19 vaccine, which is in Phase II clinical trial. It also develops influenza and breast cancer vaccine, which is in Pha...
Where does EXPRS2.ST trade?
ExpreS2ion Biotech Holding AB (publ) (EXPRS2.ST) trades on the Stockholm Stock Exchange.
What sector is EXPRS2.ST in?
ExpreS2ion Biotech Holding AB (publ) (EXPRS2.ST) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of ExpreS2ion Biotech Holding AB (publ)?
Bent U. Frandsen is the chief executive officer of ExpreS2ion Biotech Holding AB (publ) (EXPRS2.ST).
Where is ExpreS2ion Biotech Holding AB (publ) headquartered?
ExpreS2ion Biotech Holding AB (publ) is headquartered in Denmark.
Does EXPRS2.ST pay a dividend?
ExpreS2ion Biotech Holding AB (publ) (EXPRS2.ST) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did EXPRS2.ST go public?
ExpreS2ion Biotech Holding AB (publ) (EXPRS2.ST) completed its initial public offering in 2016.